Ropes & Gray: Supreme Court Agrees to Decide Securities Class Action with Significant Implications for the Pharmaceutical Industry and Other Issuers | Practical Law
This Ropes & Gray LLP memorandum discusses the Supreme Court's decision to hear the case of Matrixx Initiatives, Inc. v. Siracusano, which addresses a stockholder's claim that a pharmaceutical company improperly failed to disclose adverse drug reactions even though the events were not statistically significant.